REVIEW PAPER
ADVERSE DRUG REACTIONS IN AUDIOLOGY, PHONIATRICS, AND OTORHINOLARYNGOLOGY
,
 
,
 
,
 
,
 
 
 
 
More details
Hide details
1
Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Warsaw, Poland
 
2
Faculty of Pharmacy, Medical University of Warsaw, Poland
 
3
Pharmacotherapy and Pharmacutical Care Department, Medical University of Warsaw, Poland
 
4
Center of Hearing and Speech Medincus, Kajetany, Poland
 
5
Institute of Sensory Organs, Kajetany, Poland
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
 
 
Submission date: 2025-01-24
 
 
Acceptance date: 2025-05-22
 
 
Online publication date: 2025-07-25
 
 
Publication date: 2025-10-08
 
 
Corresponding author
Magdalena B. Skarzynska   

Institute of Sensory Organs, Mokra 1, Kajetany, 05-830 Nadarzyn, Poland
 
 
J Hear Sci 2025;15(2):23-28
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Due to the growing number of registered medicinal products, it is important to know about their mechanisms of action and adverse side effects. This also applies when diagnosing an otorhinolaryngology patient. The aim of this study was to review the literature and summarise various active substances and their relevant adverse effects.

Material and methods:
Available literature data and summary of product characteristics were analysed. The following adverse reactions were studied: dizziness, hoarseness, oral candidiasis, pharyngitis, ototoxicity, painful swelling of the salivary glands, nasal congestion, dysgeusia, nosebleeds, tinnitus, dry nose, and difficulty swallowing. To classify adverse reactions the MeDRA classification was used.

Results:
A list of individual adverse reactions and active substances that may cause them was prepared, along with the mechanism of causing a given adverse reaction. Dizziness was found to be caused by the largest number of drugs analyzed. The most severe adverse effects were irreversible ototoxicity (e.g., caused by intravenous aminoglycoside antibiotics) and embryotoxicity.

Conclusions:
Adverse effects of medicinal substances important in otorhinolaryngology, audiology, and phoniatrics are multifactorial, but knowledge of them is necessary to make a correct diagnosis.
FUNDING
This research and article did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
REFERENCES (19)
1.
Hinneburg I. [Adverse Drug Effects]. Warszawa: MedPharm; 2019 [in Polish].
 
2.
Orzechowska-Juzwenko K. [Clinical Pharmacology – Significance in Medical Practice]. Wrocław: Górnicki Wydawnictwo Medyczne; 2020 [in Polish].
 
3.
Kostka-Trąbka E, Woroń J. [Drug interactions in clinical practice]. 2nd Edition. Warszawa: PZWL; 2014 [in Polish].
 
4.
Tymiński R, Woroń J. [Adverse drug interactions – clinical and legal aspects]. 1st Edition. Warszawa: Medical Tribune Polska; 2020 [in Polish].
 
5.
Brunton L, Knollman B, Hilal-Dandan R. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, Thirteenth Edition. McGraw-Hill Education; 2017.
 
6.
Gold R, Buttgereit F, Toyka KV. Mechanism of action of glucocorticoid hormones: possible implications for the therapy of neuroimmune disorders. J Neuroimmunol, 2001; 117(1–2): 1–8. https://doi.org/10.1016/s0165-....
 
7.
Khezrian M, McNeil CJ, Murray AD, Myint PK. A review of the prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf, 2020; 11: 2042098620933741. https://doi.org/10.1177/204209....
 
8.
Mutebi A, Warholak TL, Hines LE, Plummer R, Malone DC. Assessing patients’ information needs regarding drug–drug interactions. J Am Pharm Assoc, 2013; 53(1): 39–45. https://doi.org/10.1331/JAPhA....
 
9.
Jachowicz R. [Practical Pharmacy]. 2nd Edition, Vol. 1. Warszawa: PZWL; 2016 [in Polish].
 
10.
Sznitowska M, Kaliszan R. [Biopharmacy]. Wrocław: Elsevier Urban & Partner; 2014 [in Polish].
 
11.
Rang HP, Dale MM, Ritter JM, Flower R, Henderson G. [Pharmacology]. 2nd Edition. Mirowska-Guzel D, Członkowski A, Editors. Wrocław: Elsevier Urban & Partner; 2014 [in Polish].
 
12.
Jaehde U, Radziwiłł R, Kloft C. [Clinical Pharmacy]. Wrocław: MedPharm Polska; 2014 [in Polish].
 
13.
Mutschler E, Geisslinger G, Kroemer HK, Ruth P. Mutschler Pharmacology and Toxicology. Droździk M, Kocić I, Pawlak D, Editors. Wrocław: MedPharm Polska; 2016 [in Polish].
 
14.
Korbut R. [Pharmacology]. 2nd Edition. Warszawa: PZWL; 2017 [in Polish].
 
15.
Maciejczyk A, Kruk M. [Pharmacotherapy safety. Handbook of Pharmacovigilance]. Warszawa: MediPage; 2017 [in Polish].
 
16.
Schafer C, Liekweg A, Eisert A. Pharmacotherapy in Geriatrics. Bień B, Wojszel ZB, Wieczorowska-Tobis K, Pawlak D, Editors. Wrocław: MedPharm Polska, 2016 [in Polish].
 
17.
Derendorf H, Gramatte T, Schäfer HG, Staab A. [Pharmacokinetics. Basics and practical significance]. Wyska E, Editor. Wrocław: MedPharm Polska; 2013 [in Polish].
 
18.
Summary of Product Characteristics (SmPC). Available at: https://www.ema.europa.eu/en/g... [Accessed 20.04.2025].
 
19.
[Pharmacotherapy in Otorhinolaryngology. Compendium]. 1st Edition. Olszewski J, Editor. Warszawa: PZWL; 2025 [in Polish].
 
Journals System - logo
Scroll to top